Cargando…
Saliva Versus Plasma Bioequivalence of Azithromycin in Humans: Validation of Class I Drugs of the Salivary Excretion Classification System
AIM: The aim of this study was to compare human pharmacokinetics and bioequivalence metrics in saliva versus plasma for azithromycin as a model class I drug of the Salivary Excretion Classification System (SECS). METHODS: A pilot, open-label, two-way crossover bioequivalence study was done, and invo...
Autores principales: | Idkaidek, Nasir, Arafat, Tawfiq, Hamadi, Hazim, Hamadi, Salim, Al-Adham, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318338/ https://www.ncbi.nlm.nih.gov/pubmed/28074334 http://dx.doi.org/10.1007/s40268-016-0170-8 |
Ejemplares similares
-
Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
por: Idkaidek, Nasir, et al.
Publicado: (2015) -
Erratum to: Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
por: Idkaidek, Nasir, et al.
Publicado: (2015) -
Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans
por: Idkaidek, Nasir M.
Publicado: (2017) -
Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status
por: Mallah, Eyad M, et al.
Publicado: (2011) -
Automatic detection of COVID-19 using pruned GLCM-Based texture features and LDCRF classification
por: Bakheet, Samy, et al.
Publicado: (2021)